Peel Hunt reaffirmed their buy rating on shares of CVS Group (LON:CVSG) in a research note issued to investors on Thursday, January 4th. The firm currently has a GBX 1,350 ($18.96) target price on the stock.

Separately, Berenberg Bank reaffirmed a buy rating and issued a GBX 1,450 ($20.36) price target on shares of CVS Group in a research note on Wednesday, December 6th.

CVS Group (LON CVSG) traded up GBX 26 ($0.37) during midday trading on Thursday, reaching GBX 1,209 ($16.98). 228,876 shares of the company’s stock traded hands, compared to its average volume of 233,896. The company has a market cap of $780.01 and a PE ratio of 6,716.67. CVS Group has a 1 year low of GBX 13.22 ($0.19) and a 1 year high of GBX 1,500 ($21.06).

In other CVS Group news, insider Richard A. Connell bought 2,061 shares of the business’s stock in a transaction that occurred on Thursday, December 7th. The stock was acquired at an average cost of GBX 920 ($12.92) per share, with a total value of £18,961.20 ($26,627.16).

TRADEMARK VIOLATION WARNING: This article was first posted by Marea Informative and is owned by of Marea Informative. If you are viewing this article on another domain, it was illegally copied and reposted in violation of US and international copyright & trademark legislation. The original version of this article can be viewed at

About CVS Group

CVS Group plc is a holding company. The principal activities of the Company are to operate animal veterinary practices, veterinary diagnostic businesses, pet crematoria and an online pharmacy and retail business. Its segments are Veterinary Practice, Laboratories, Pet Crematoria and Animed Direct. The Veterinary Practice segment offers treatment for companion animals, equine and farm animals.

Receive News & Ratings for CVS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Group and related companies with's FREE daily email newsletter.